Response to safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience

被引：0
|
作者：
Julie Blanc
Laurent Kodjikian
Alain Bron
Catherine Creuzot-Garcher
机构：
[1] University Hospital,
[2] University Hospital,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2018年 / 256卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2271 / 2271
相关论文
共 50 条
  • [31] Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
    Calugaru, Dan
    Calugaru, Mihai
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (06) : 1209 - 1210
  • [32] Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
    Xiaoxin Li
    Ningli Wang
    Xiaoling Liang
    Gezhi Xu
    Xiao-Yan Li
    Jenny Jiao
    Jean Lou
    Yehia Hashad
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 59 - 69
  • [33] Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study
    Georgalas, Iias
    Tservakis, Ioannis
    Kiskira, Eftychia Eleftheria
    Petroua, Petros
    Papaconstantinou, Dimitris
    Kanakis, Menelaos
    CUTANEOUS AND OCULAR TOXICOLOGY, 2019, 38 (04) : 330 - 337
  • [34] Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) for the Treatment of Persistent Macular Edema Secondary to Retinal Vein Occlusion in Eyes Previously Treated with Anti- Vascular Endothelial Growth Factors
    Tservakis, Ioannis
    Koutsandrea, Chryssanthi
    Papaconstantinou, Dimitrios
    Paraskevopoulos, Theodore
    Georgalas, Ilias
    CURRENT DRUG SAFETY, 2015, 10 (02) : 145 - 151
  • [35] Long-Term Outcomes in Early versus Limited Response to Anti-VEGF Treatment for Retinal Vein Occlusion
    Kailar, Roshni S.
    Kuo, Blanche L.
    Perkins, Scott W.
    Singh, Rishi P.
    OPHTHALMOLOGY, 2024, 131 (02) : 131 - 131
  • [36] Long-Term Outcomes in Early versus Limited Response to Anti-VEGF Treatment for Retinal Vein Occlusion
    Kailar, Roshni S.
    Kuo, Blanche L.
    Perkins, Scott W.
    Singh, Rishi P.
    OPHTHALMOLOGY RETINA, 2024, 8 (01): : 55 - 61
  • [37] Did the anti-VEGF therapy actually change the long-term prognosis of macular edema in branch retinal vein occlusion patients?
    Lee, SeungHyun
    Yoon, Myung Hun
    Chin, Hee Seung
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [38] Author's reply to comments to: Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema
    Matonti, Frederic
    Soler, Vincent
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (06) : E173 - E173
  • [39] Comparison of the efficiency of anti-VEGF drugs intravitreal injections treatment with or without retinal laser photocoagulation for macular edema secondary to retinal vein occlusion: A systematic review and meta-analysis
    Zou, Weijie
    Du, Yuanyuan
    Ji, Xiaoyan
    Zhang, Ji
    Ding, Hongping
    Chen, Jingqiao
    Wang, Tao
    Ji, Fangfang
    Huang, Jiang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [40] Impact of treatment on long-term visual function in retinal vein occlusion—response to the comment on: retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
    Justus G. Garweg
    Souska Zandi
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 2479 - 2480
12345